Genotech Corporation (XKON:066830)
South Korea · Delayed Price · Currency is KRW 1,100.00
-99.00 (-8.26%)
At close: Nov 13, 2026
Genotech Market Cap
Genotech has a market cap or net worth of 6.16 billion as of November 13, 2026. It is the 44,750th most valuable company in the world and the 2,694th biggest in South Korea. Its market cap has increased by 0.09% in one year.
Market Cap
6.16B
Enterprise Value
n/a
Revenue
7.28B
Global Rank
Country Rank
#2,694 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Genotech's market cap has decreased from 30.32B to 6.16B, a decrease of -79.69%. That is a compound annual growth rate of -15.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 6.16B | 0.36% |
| Dec 29, 2025 | 6.14B | -15.56% |
| Dec 30, 2024 | 7.27B | -31.58% |
| Dec 28, 2023 | 10.62B | -34.36% |
| Dec 29, 2022 | 16.18B | -23.65% |
| Dec 30, 2021 | 21.19B | 6.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Progen | 27.43B |
| Epibiotech | 25.88B |
| ADBiotech | 20.62B |
| Poongjeon Pharmacy CO.,LTD. | 20.51B |
| Shaperon | 19.61B |
| Moogene Medi | 18.90B |
| Plumbline Life Sciences | 18.69B |
| NGeneBio | 14.96B |